Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...
Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.
Seattle-based Sana Biotechnology Inc. (Nasdaq: SANA) is losing its research and development lead. In a Thursday filing with ...
April 5 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales there of its biosimilar version of AbbVie’s blockbuster arthritis treatment ...
Due to slow uptake of its Humira biosimilar Cyltezo in the U.S., Boehringer Ingelheim is laying off an undisclosed number of ...
The stock of AMGEN Inc. (AMGN) has gone down by -2.12% for the week, with a -1.24% drop in the past month and a -13.03% drop in the past quarter. The volatility ratio for the week is 1.88%, and the ...
Even with discounts that reach as high as 86%, Humira biosimilars are finding it difficult to take market share away from the ...
Wall Street stocks were in the green early on Monday as retail sales boosted sentiment and market participants prepared for ...
US stocks were mostly lower on Thursday with the S&P 500 and Nasdaq falling for the fifth straight day as another rise in ...
, opens new tab said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical hold on early-stage study of its experimental schizophrenia drug, sending its shares down more than 23% ...
In this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024. For a quick ...